Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium species asexual blood stage encompasses the period when malaria parasites actively invade and multiply within human erythrocytes (red blood cells). After being released from the liver as merozoites, Plasmodium invades red blood cells and undergoes repeated cycles of growth and division (schizogony), leading to exponential increases in parasite numbers. This stage is responsible for most clinical symptoms of malaria, as parasites digest host hemoglobin, causing anemia and releasing metabolic waste that triggers fever and inflammation. Key cellular processes include hemoglobin ingestion, glycolytic ATP production, heme detoxification into hemozoin, and immune evasion. Asexual blood stages are the main target for most antimalarial drugs, and their effective clearance is essential to treat malaria and prevent morbidity and mortality.
Inhibition of hemoglobin digestion; Disruption of heme detoxification; Inhibition of DNA/RNA synthesis and replication; Inhibition of mitochondrial electron transport chain; Inhibition of folate pathway enzymes; Disruption of membrane processes
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium species asexual blood stage.